- call +1-201-465-4211
- email sales@mrinsights.biz
Biosimulation techonlogy is a mathematical simulation of biological process in which computer aided programs are used for the simulation of biological processes and systems. It is also known as model-based drug development that has ability to make data-driven decisions at all stages of drug development through a quantitative framework. Biosimulation is a promising technology that especially used in pharmaceutical research to improve the drug discovery and development cycle of a drug.
Scope of the Report:
This report studies the Biosimulation Technology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimulation Technology market by product type and applications/end industries.
The global Biosimulation Technology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biosimulation Technology.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Certara USA
Simulation Plus
Dassault Systèmes
Schrodinger
Advanced Chemistry Development
Chemical Computing Group
Entelos
Genedata
Physiomics
Rhenovia Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Software
Service
Market Segment by Applications, can be divided into
Drug development
Drug discovery
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biosimulation Technology Market Overview
1.1 Product Overview and Scope of Biosimulation Technology
1.2 Classification of Biosimulation Technology by Types
1.2.1 Global Biosimulation Technology Revenue Comparison by Types (2017-2023)
1.2.2 Global Biosimulation Technology Revenue Market Share by Types in 2017
1.2.3 Software
1.2.4 Service
1.3 Global Biosimulation Technology Market by Application
1.3.1 Global Biosimulation Technology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Drug development
1.3.3 Drug discovery
1.3.4 Others
1.4 Global Biosimulation Technology Market by Regions
1.4.1 Global Biosimulation Technology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biosimulation Technology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biosimulation Technology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimulation Technology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biosimulation Technology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimulation Technology Status and Prospect (2013-2023)
1.5 Global Market Size of Biosimulation Technology (2013-2023)
2 Manufacturers Profiles
2.1 Certara USA
2.1.1 Business Overview
2.1.2 Biosimulation Technology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Certara USA Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.2 Simulation Plus
2.2.1 Business Overview
2.2.2 Biosimulation Technology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Simulation Plus Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dassault Systèmes
2.3.1 Business Overview
2.3.2 Biosimulation Technology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Dassault Systèmes Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.4 Schrodinger
2.4.1 Business Overview
2.4.2 Biosimulation Technology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Schrodinger Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Advanced Chemistry Development
2.5.1 Business Overview
2.5.2 Biosimulation Technology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Advanced Chemistry Development Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.6 Chemical Computing Group
2.6.1 Business Overview
2.6.2 Biosimulation Technology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Chemical Computing Group Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.7 Entelos
2.7.1 Business Overview
2.7.2 Biosimulation Technology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Entelos Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.8 Genedata
2.8.1 Business Overview
2.8.2 Biosimulation Technology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Genedata Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.9 Physiomics
2.9.1 Business Overview
2.9.2 Biosimulation Technology Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Physiomics Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
2.10 Rhenovia Pharma
2.10.1 Business Overview
2.10.2 Biosimulation Technology Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Rhenovia Pharma Biosimulation Technology Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biosimulation Technology Market Competition, by Players
3.1 Global Biosimulation Technology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biosimulation Technology Players Market Share
3.2.2 Top 10 Biosimulation Technology Players Market Share
3.3 Market Competition Trend
4 Global Biosimulation Technology Market Size by Regions
4.1 Global Biosimulation Technology Revenue and Market Share by Regions
4.2 North America Biosimulation Technology Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimulation Technology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimulation Technology Revenue and Growth Rate (2013-2018)
4.5 South America Biosimulation Technology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimulation Technology Revenue and Growth Rate (2013-2018)
5 North America Biosimulation Technology Revenue by Countries
5.1 North America Biosimulation Technology Revenue by Countries (2013-2018)
5.2 USA Biosimulation Technology Revenue and Growth Rate (2013-2018)
5.3 Canada Biosimulation Technology Revenue and Growth Rate (2013-2018)
5.4 Mexico Biosimulation Technology Revenue and Growth Rate (2013-2018)
6 Europe Biosimulation Technology Revenue by Countries
6.1 Europe Biosimulation Technology Revenue by Countries (2013-2018)
6.2 Germany Biosimulation Technology Revenue and Growth Rate (2013-2018)
6.3 UK Biosimulation Technology Revenue and Growth Rate (2013-2018)
6.4 France Biosimulation Technology Revenue and Growth Rate (2013-2018)
6.5 Russia Biosimulation Technology Revenue and Growth Rate (2013-2018)
6.6 Italy Biosimulation Technology Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biosimulation Technology Revenue by Countries
7.1 Asia-Pacific Biosimulation Technology Revenue by Countries (2013-2018)
7.2 China Biosimulation Technology Revenue and Growth Rate (2013-2018)
7.3 Japan Biosimulation Technology Revenue and Growth Rate (2013-2018)
7.4 Korea Biosimulation Technology Revenue and Growth Rate (2013-2018)
7.5 India Biosimulation Technology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biosimulation Technology Revenue and Growth Rate (2013-2018)
8 South America Biosimulation Technology Revenue by Countries
8.1 South America Biosimulation Technology Revenue by Countries (2013-2018)
8.2 Brazil Biosimulation Technology Revenue and Growth Rate (2013-2018)
8.3 Argentina Biosimulation Technology Revenue and Growth Rate (2013-2018)
8.4 Colombia Biosimulation Technology Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biosimulation Technology by Countries
9.1 Middle East and Africa Biosimulation Technology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biosimulation Technology Revenue and Growth Rate (2013-2018)
9.3 UAE Biosimulation Technology Revenue and Growth Rate (2013-2018)
9.4 Egypt Biosimulation Technology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biosimulation Technology Revenue and Growth Rate (2013-2018)
9.6 South Africa Biosimulation Technology Revenue and Growth Rate (2013-2018)
10 Global Biosimulation Technology Market Segment by Type
10.1 Global Biosimulation Technology Revenue and Market Share by Type (2013-2018)
10.2 Global Biosimulation Technology Market Forecast by Type (2018-2023)
10.3 Software Revenue Growth Rate (2013-2023)
10.4 Service Revenue Growth Rate (2013-2023)
11 Global Biosimulation Technology Market Segment by Application
11.1 Global Biosimulation Technology Revenue Market Share by Application (2013-2018)
11.2 Biosimulation Technology Market Forecast by Application (2018-2023)
11.3 Drug development Revenue Growth (2013-2018)
11.4 Drug discovery Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Biosimulation Technology Market Size Forecast (2018-2023)
12.1 Global Biosimulation Technology Market Size Forecast (2018-2023)
12.2 Global Biosimulation Technology Market Forecast by Regions (2018-2023)
12.3 North America Biosimulation Technology Revenue Market Forecast (2018-2023)
12.4 Europe Biosimulation Technology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biosimulation Technology Revenue Market Forecast (2018-2023)
12.6 South America Biosimulation Technology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biosimulation Technology Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biosimulation Technology Picture
Table Product Specifications of Biosimulation Technology
Table Global Biosimulation Technology and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
